Pharmacology of second-generation antipsychotics: A validity of the serotonin-dopamine hypothesis

Pharmacology, Toxicology and Pharmaceutical Science

• Antipsychotic 100%
• Receptor 66%
• Dopamine 55%
• Serotonin 44%
• Atypical Antipsychotics 33%
• Clozapine 22%
• Drug 11%
• Incidence 11%
• Base 11%
• Olanzapine 11%
• Risperidone 11%
• Receptor Subtype 11%
• Quetiapine 11%
• Extrapyramidal Symptoms 11%

Neuroscience

• Antipsychotic 100%
• Eicosanoid Receptor 44%
• Dopamine 44%
• Serotonin 44%
• Atypical Antipsychotic 33%
• Clozapine 22%
• Receptor Subtype 11%
• Risperidone 11%
• Olanzapine 11%
• Prefrontal Cortex 11%
• Dopamine Release 11%
• 5-HT2A Receptor 11%
• 5-HT1A Receptor 11%
• 5-HT Receptor 11%
• Cognitive Effect 11%
• Quetiapine 11%